Xiaosong Zhang MD
Clinical Fellow in Hematology Oncology, University of California at San Francisco
Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Phone+1 415-885-7276
Fax+1 617-724-7441
Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2013 - 2016
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
Peking Union Medical CollegeClass of 2004
Certifications & Licensure
CA State Medical License 2013 - 2026
WA State Medical License 2016 - 2017
MA State Medical License 2012 - 2015
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Encorafenib, Cetuximab, and mFOLFOX6 in-Mutated Colorectal Cancer.Elena Elez, Takayuki Yoshino, Lin Shen, Sara Lonardi, Eric Van Cutsem
The New England Journal of Medicine. 2025-06-26 - Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report.Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, Ibiayi Dagogo-Jack, Raymond Esper
Journal of Thoracic Oncology. 2025-06-04 - A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study.Scott Kopetz, Danielle A Murphy, Jie Pu, Fortunato Ciardiello, Jayesh Desai
Future Oncology. 2025-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
